Table 2.
Human HNSCC cell lines | Gender | Stage | Primary tumor site | HPV status | |
---|---|---|---|---|---|
HPV-NEG HNSCC | VU-SCC-040a | Female | T3N0 | Tongue | Negative |
VU-SCC-11B‡ | Male | T2N2a | Supraglottic larynx | Negative | |
UM-SCC-22A | Female | T2N1 | Hypopharynx | Negative | |
UM-SCC-6 | Male | T2N0 | Base of tongue | Negative | |
VU-SCC-120 | Female | T3N1 | Tongue | Negative | |
VU-SCC-096 | Male | T4N1 | Retromolar trigone | Negative | |
FaDub | Male | NA | Hypopharynx | Negative | |
FA-HNSCC | VU-SCC-1604 | Female | NA | Tongue | Negative |
VU-SCC-1131‡ | Female | T4N2b | Floor of mouth | Negative |
NA not annotated. aTP53 wild-type cell line. bCell line from a sporadic HNSCC tumor with a de novo Fanconi gene mutation [47]. ‡Local recurrences of primary tumo